For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Rotorua GPCME 2025
Over 1000 delegates, speakers and exhibitors from across the health sector attended Rotorua GPCME 2025. New Zealand Doctor Rata Aotearoa editor Barbara Fountain, deputy editor Patrice Dougan, and reporters Alan Perrott and Zach Thompson were on hand to sit in on the sessions and workshops and meet the many people who walked through the doors of the city's Energy Events Centre between 5 and 8 June.